Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Radiother Oncol. 2009 Jun 10;93(3):510–515. doi: 10.1016/j.radonc.2009.05.013

Fig 3.

Fig 3

Differences in the T2-weighted signals from pre- to 3 months post-therapy vs. mean doses to the muscles. 1A: pharyngeal constrictors (PCs), 1B: sternocleidomastoid muscles (SCMs).